TherapeuticsMD Inc.

NASDAQ: TXMD · Real-Time Price · USD
1.17
0.02 (1.72%)
At close: Aug 15, 2025, 3:58 PM
1.18
0.86%
After-hours: Aug 15, 2025, 07:44 PM EDT

TherapeuticsMD Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
5.06M 4.33M 38.07M 65.12M
Short-Term Investments
n/a n/a n/a n/a
Long-Term Investments
16.01M n/a 20.25M n/a
Other Long-Term Assets
130K 18.54M 20.51M 253K
Receivables
3.56M 3.09M n/a 36.18M
Inventory
n/a n/a n/a 7.62M
Other Current Assets
3.64M 4.13M 16.12M 8.46M
Total Current Assets
12.26M 11.8M 55.35M 119.47M
Property-Plant & Equipment
6.1M 6.87M 7.66M 9.43M
Goodwill & Intangibles
4.32M 6.1M 6.94M 40.32M
Total Long-Term Assets
26.56M 31.51M 35.11M 50M
Total Assets
38.82M 43.31M 90.46M 169.47M
Account Payables
258K 27K 2.16M 3.37M
Deferred Revenue
n/a n/a 1.01M 39.59M
Short-Term Debt
1.63M n/a n/a 188.27M
Other Current Liabilities
1.15M 3.69M 30.53M 53.34M
Total Current Liabilities
5.17M 6.85M 46.84M 252.89M
Long-Term Debt
n/a n/a n/a n/a
Other Long-Term Liabilities
744K 636K 1.11M 2.14M
Total Long-Term Liabilities
6.29M 7.17M 8.48M 10.2M
Total Liabilities
11.45M 14.02M 55.31M 263.09M
Total Debt
7.17M 8.01M 8.76M 196.33M
Common Stock
11K 11K 9K 430K
Retained Earnings
-951.82M -949.64M -939.36M -1.05B
Comprehensive Income
n/a -0.00 0.00 -0.00
Shareholders Equity
27.37M 29.29M 35.14M -93.62M
Total Investments
16.01M 18.48M 20.25M n/a